Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Respiratory investigation 2020-11, Vol.58 (6), p.510-512
Hauptverfasser:	Nakamura, Hideta, Miyagi, Kazuya, Otsuki, Mariko, Higure, Yuuri, Nishiyama, Naoya, Kinjo, Takeshi, Nakamatsu, Masashi, Haranaga, Shusaku, Tateyama, Masao, Fujita, Jiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized - therapeutic use COVID-19 - drug therapy Cytokine Release Syndrome - drug therapy Cytokine Release Syndrome - virology Humans Interleukin-6 - antagonists & inhibitors Japan - epidemiology Letter to the Editor Respiratory Distress Syndrome - drug therapy Respiratory Distress Syndrome - virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!